273 related articles for article (PubMed ID: 32633270)
1. [Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis].
Ak Sivrikoz I; Çavuşoğlu Y
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):514-521. PubMed ID: 32633270
[TBL] [Abstract][Full Text] [Related]
2. Cardiac amyloidosis: Recent advances in the diagnosis and therapy.
Çavuşoğlu Y; Özpelit E; Çelik A; İkitimur B; Kayıkçıoğlu M; Tokgözoğlu L; Tüfekçioğlu O; Yılmaz MB
Turk Kardiyol Dern Ars; 2019 Jun; 47(Suppl 2):1-34. PubMed ID: 31364995
[TBL] [Abstract][Full Text] [Related]
3. Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy.
Murat S; Çavuşoğlu Y; Ak Sivrikoz İ
Turk Kardiyol Dern Ars; 2021 Oct; 49(7):579-584. PubMed ID: 34623301
[TBL] [Abstract][Full Text] [Related]
4. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
[TBL] [Abstract][Full Text] [Related]
5. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
Tini G; Sessarego E; Benenati S; Vianello PF; Musumeci B; Autore C; Canepa M
Eur J Clin Invest; 2021 Dec; 51(12):e13665. PubMed ID: 34390490
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
[TBL] [Abstract][Full Text] [Related]
7.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
9. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
10. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Chen W; Ton VK; Dilsizian V
Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
[TBL] [Abstract][Full Text] [Related]
11. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
Morfino P; Aimo A; Giorgetti A; Genovesi D; Merlo M; Limongelli G; Castiglione V; Vergaro G; Emdin M
Heart Fail Clin; 2024 Jul; 20(3):307-316. PubMed ID: 38844301
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.
Bianco M; Parente A; Biolè C; Righetti C; Spirito A; Luciano A; Destefanis P; Nangeroni G; Angusti T; Anselmino M; Montagna L
J Nucl Cardiol; 2021 Jun; 28(3):825-830. PubMed ID: 33728572
[TBL] [Abstract][Full Text] [Related]
13. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Damy T; Jaccard A; Guellich A; Lavergne D; Galat A; Deux JF; Hittinger L; Dupuis J; Frenkel V; Rigaud C; Plante-Bordeneuve V; Bodez D; Mohty D
Amyloid; 2016 Sep; 23(3):194-202. PubMed ID: 27647161
[TBL] [Abstract][Full Text] [Related]
15. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
[TBL] [Abstract][Full Text] [Related]
16. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
[TBL] [Abstract][Full Text] [Related]
18. The Most Predictive Red Flags for Suspecting Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction.
Yalvaç HE; Murat S; Ak Sivrikoz İ; Üsküdar Teke H; Çilingir O; Çolak E; Çavuşoğlu Y
Turk Kardiyol Dern Ars; 2024 Jun; 52(4):227-236. PubMed ID: 38829635
[TBL] [Abstract][Full Text] [Related]
19. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
